The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of comorbidities using Adult Comorbidity Evaluation-27 (ACE-27) score on survival in stage II colon cancer: Age, TNM staging, and pathological high risk-disease.
 
Manik A. Amin
No Relationships to Disclose
 
Andrea Wang-Gillam
No Relationships to Disclose
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Rama Suresh
No Relationships to Disclose
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk
Research Funding - Agensys; Altor BioScience; BioClin Therapeutics; Novartis; Oncogenex
 
Preet Paul Singh
No Relationships to Disclose
 
Kian-Huat Lim
No Relationships to Disclose
 
Ashiq Masood
No Relationships to Disclose
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)